4161 logo

Bioptik Technology Incorporation Stock Price

TPEX:4161 Community·NT$1.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4161 Share Price Performance

NT$24.60
-2.88 (-10.47%)
NT$24.60
-2.88 (-10.47%)
Price NT$24.60

4161 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

3 Risks
1 Reward

Bioptik Technology Incorporation Key Details

NT$837.2m

Revenue

NT$593.7m

Cost of Revenue

NT$243.5m

Gross Profit

NT$172.3m

Other Expenses

NT$71.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.19
29.09%
8.50%
39.7%
View Full Analysis

About 4161

Founded
1999
Employees
n/a
CEO
n/a
WebsiteView website
www.bioptik.com.tw

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. It offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch Glucose Monitoring System for Dogs and Cats. The company also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, cream/lotion, make-up removal, shampoo, time capsule, and toner/essence; and skin care products. It is involved in manufacturing of feed and food additive, aircraft and parts, and chemicals; wholesale and import and export trade of cosmetics raw materials, semi-finished products and finished products; cosmetics retail and wholesale; and special forestry management. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.

Recent 4161 News & Updates

Recent updates

No updates